Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
13.78
-0.29 (-2.06%)
Nov 13, 2026, 9:56 AM EST - Market open
Biohaven Market Cap
Biohaven has a market cap or net worth of $2.08 billion as of November 13, 2026. It is the 6,332nd most valuable company in the world and the 1,710th biggest in the United States. Its market cap has increased by 102.68% in one year.
Market Cap
2.08B
Enterprise Value
2.22B
1-Year Change
102.68%
Global Rank
Country Rank
#1,710 United States
Category
ChartMarket Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $2.08B, an increase of 695.78%. That is a compound annual growth rate of 64.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.08B | 38.95% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 2.24B |
| Palvella Therapeutics | 2.24B |
| Immunome | 2.21B |
| Lakefront Biotherapeutics NV | 2.20B |
| Aurinia Pharmaceuticals | 2.17B |
| Vera Therapeutics | 2.10B |
| Replimune Group | 2.08B |
| Recursion Pharmaceuticals | 2.08B |